Multiple Myeloma — Trials

Multiple Myeloma — Trials · CancerIndex

Clinical trials

Registered studies

3,384 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 814
Recruiting: 414
Ph III recruiting: 54
Growth YoY: +13.3%
Industry share: 29%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.1%
Trials / 1,000 deaths: 70.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (537)

clinicaltrialsPublishedShowing 51–100 of 141 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07646873	PET-Enabled Dual-Energy CT in Multiple Myeloma	not yet recruiting	N/A	45	University of California, DavisOTHER	1	Jun 15, 2026	clinicaltrials
NCT07628595	Safety and Efficacy of RN9101 in the Treatment of Relapsed/Refractory Multiple Myeloma	not yet recruiting	Early Phase 1	19	The First Affiliated Hospital with Nanjing Medical UniversityOTHER	1	Jun 10, 2026	clinicaltrials